CN Patent

CN117545482A — 使用醛固酮合酶抑制剂的方法

Assigned to Xinke Pharmaceutical Co · Expires 2024-02-09 · 2y expired

What this patent protects

本披露提供了在有需要的受试者中抑制人醛固酮合酶、治疗高血压或治疗原发性醛固酮增多症的方法，这些方法包括向该受试者施用有效量的(R)‑化合物1，其中(R)‑化合物1为：式(I)。

USPTO Abstract

本披露提供了在有需要的受试者中抑制人醛固酮合酶、治疗高血压或治疗原发性醛固酮增多症的方法，这些方法包括向该受试者施用有效量的(R)‑化合物1，其中(R)‑化合物1为：式(I)。

Drugs covered by this patent

paltusotine-hydrochloride (PALTUSOTINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN117545482A
Jurisdiction: CN
Classification: —
Expires: 2024-02-09
Drug substance claim: No
Drug product claim: No
Assignee: Xinke Pharmaceutical Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.